DEUTSCHE BANK AG\
BankPosition in OLMA — Olema Pharmaceuticals, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in OLMA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,198,882
-$1,207,531 QoQ
Shares Held
95,834
-40.6% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 182 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 17%
Shared 0%
None 83%
Common Shares in OLMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. OLMA ranks #135 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in OLMA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,198,882 | 95,834 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $2,406,413 | 161,396 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $1,576,675 | 63,067 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $598,090 | 61,092 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $230,508 | 54,110 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $204,276 | 54,329 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $229,299 | 39,331 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $323,955 | 27,132 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $2,746,916 | 253,874 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $2,819,018 | 249,030 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $3,488,712 | 248,661 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $179,296 | 14,518 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $2,245,715 | 248,695 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $883,870 | 254,718 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,118,831 | 456,666 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,260,397 | 456,666 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,858,629 | 456,666 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $240,421 | 56,437 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,003,063 | 107,165 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $2,926,456 | 106,185 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $2,772,564 | 99,091 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $447,132 | 13,476 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||